openPR Logo
Press release

Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025

02-11-2019 04:17 PM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Rise in Prevalence of Migraine Drives the Migraine Drugs Market |

Migraine is characterized by a recurrent throbbing headache, which affects only one side of the head. It is accompanied by vomiting, nausea and even altered vision in some cases.

The increase in the prevalence of migraine, the rapid increase in the female population and the increased awareness among patients for the treatment and prevention of migraine are driving the growth of the global market for anti-migraine drugs.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-sample/2811?utm_source=openpr_ss

However, the side effects of migraine medications are expected to limit market growth. On the contrary, it is expected that new emerging therapies / medications for the treatment of migraine and growth opportunities in emerging countries present opportunities for market growth during the forecast period.

By type, abortifacient drugs accounted for more than three quarters of the global market for migraine drugs in 2017. In addition, by administration, the oral segment is expected to grow at the highest rate of 3.4% during the forecast period.

Send Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/2811?utm_source=openpr_ss

Key Market Players:

• Abbott Laboratories
• Allergan Plc.
• AstraZeneca
• Eisai Co. Ltd.
• Endo International Plc.
• GlaxoSmithKline Plc.
• Impax Laboratories

Key Findings of Migraine Drugs Market:

•North America occupied the two-fifths of the world market for migraine medicines.

•It is anticipated that Oral will grow with the highest CAGR throughout the forecast period.

•It is expected that Europe will occupy more than a quarter of the market share of the global market for migraine drugs by 2025.

•It is anticipated that Asia-Pacific will grow at the highest rate during the analysis period, followed by LAMEA.

Browse More Information of Report @ https://www.alliedmarketresearch.com/press-release/migraine-drugs-market.html

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rise in Prevalence of Migraine Drives the Migraine Drugs Market | Outlook 2025 here

News-ID: 1577855 • Views: 189

More Releases from Allied Market Research

Increasing Need for Automation in Process Industries Drives the Control Valve Ma …
Control Valve Market Outlook - 2022 The global control valves market expected to reach $13,674 Million by 2022 at a CAGR of 7.6% from 2016 to 2022. Pneumatic control valves market occupied a dominant share of about 80% in 2015 and is expected to maintain its lead throughout the forecast period. By application, electric powered control valve segment accounted for about 22% of the market share in 2015. North America
Thermal Energy Storage Market Expected to Reach $8,862 Million By 2023 at a CAGR …
Thermal Energy Storage Market Outlook – 2023 The Global Thermal Energy Storage Market was valued at $3,988 Million in 2016, and is estimated to reach $8,862 Million by 2023, registering a CAGR of 10.9% from 2017 to 2023. In 2016, the sensible heat storage segment accounted for more than half share of the total market. Thermal energy storage, also known as heat storage, is a highly efficient and simple method of
Overview Membrane Technology for Food and Beverage Processing Market Size, Share …
Membranes are natural or manufactured substances used for separation. They commonly serve the purpose of filter pads. Membranes, which are semi-permeable in nature (allow only selective compounds/substances to flow pass them) are easy to manufacture. These are gaining popularity in the process industry where purity of products is highly desired. Membranes are available in every shape and size and are required in numerous devices right from the water filter at
Cooking Appliances Market is Predicted to Grow High CAGR from 2019 to 2026
The cooking appliance include products such as microwaves, ovens, cook tops, and range hoods. Modern cooking appliance are used to provide ease to chefs. Also, with rapid depletion of natural resources such as LPG, and other petroleum products, there is an urgent need to use efficient and eco-friendly cooking appliances in kitchen. Key players are developing advance cooking appliances in order to increase their market share, and on the same

All 5 Releases


More Releases for Migraine

EpiCast Report: Migraine-Epidemiology Forecast to 2026
Migraine is characterized by recurring headaches and throbbing pain on one side of the head accompanied by nausea, vomiting, or increased sensitivity to light or smell. While most migraineurs experience episodic migraines (EM), a small percentage suffers from chronic migraine (CM). In addition to its debilitating pain, migraines are also associated with more severe cardiovascular and neuropsychological comorbidities. Because migraine is one of the most prevalent types of headache, there
Migraine Therapeutics Pipeline Analysis -Results, Designation, Collaboration
Migraine is a type of a severe headache that is characterized by the intense throbbing in one area of the head. According to National Institute of Neurological Disorders and Stroke, migraine is three times common in women than in men and it is heralded by visual disturbances such as zig-zag lines vision and flashing lights. Access Report Overview: https://www.psmarketresearch.com/market-analysis/migraine-therapeutics-pipeline-analysis People having migraine generally have frequent attacks that cause, anxiety, stress,
Migraine KOL Interview
ReportsWorldwide has announced the addition of a new report title Migraine KOL Interview to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/biosimilar-insulin-market-access February 08, 2017 We interviewed a neurologist based in the US who specializes in headache medicine to gauge his current and anticipated future use of acute and prophylactic agents in the treatment of episodic
Migraine Disease Coverage Forecast and Market Analysis
ReportsWorldwide has announced the addition of a new report title Migraine Disease Coverage Forecast and Market Analysis to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/migraine-disease-coverage-forecast-and-market-analysis Introduction Migraine is a common, disabling, and recurring neurological disorder characterized by severe headache co-occurring with nausea, vomiting, and other symptoms, the duration of which can range from hours to days.
Global Migraine Market: Industry Analysis & Outlook 2021
Migraine is a chronic neurovascular disorder characterized by severe recurrent headaches. It is one of the most common and most prevalent disabling neurological conditions, characterized by episodes often called migraine attacks. They are quite different from regular headaches which are non-migrainous. Migraineurs generally have a lower threshold to triggers that might cause neuronal hyperexcitability, including sleep disturbances, environmental or emotional challenges, alcohol exposure, diet, and hormonal cycles/changes, among others. Migraine
Increasing incidences of migraine sufferers driving the Anti-Migraine Drugs Mark …
Antimigraine drugs are the therapeutic agents indicated to use against migraine headaches. Migraine is characterized by recurrent attacks of moderate to severe headaches along with other nervous system symptoms. Migraine is more common in women than men, majorly due to the fluctuations in the harmone levels. According to a Medline article, around 12% of the U.S. population suffers from migraine headaches. The two major types of migraine are classic and